Please login to the form below

Not currently logged in
Email:
Password:

Foundation Medicines

This page shows the latest Foundation Medicines news and features for those working in and with pharma, biotech and healthcare.

Pioneering research collaboration seeks cure for cystic fibrosis

Pioneering research collaboration seeks cure for cystic fibrosis

Backed by the non-profit Cystic Fibrosis Foundation and venture capital group Flagship, Pioneering Medicines will identify and develop genetic therapies for CF. ... Now, the search for a cure to CF is back on the agenda with the announcement that the US

Latest news

  • US start-up EQRx promises approach that will slash drug prices US start-up EQRx promises approach that will slash drug prices

    in 2018 – and  Blueprint Medicines which has just claimed its first approval for a high-priced cancer drug. ... Other key figures in EQRx include former Foundation Medicine and McKesson executive Melanie Nallicheri, who serves as president and chief

  • AstraZeneca to develop Lynparza companion diagnostic AstraZeneca to develop Lynparza companion diagnostic

    To do so AZ has joined forces with molecular information firm Foundation Medicines, whose FoundationOne genomic profiling platform will be used to develop the test. ... Nina Mojas, global medicine lead for Lynparza at AstraZeneca, said: “Utilising

  • The distance travelled

    When medicines were approved, the community thought that prices were too high and wanted a greater say in the development and delivery of medicines. ... Unimaginable thirty years ago, most companies now collaborate with not-for-profit organisations like

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Envisioning a healthier every day, for every woman Envisioning a healthier every day, for every woman

    These three pillars – women’s health, biosimilars and established medicines – are the foundation for how we strive to achieve this vision. ... We have a strong foundation of more than 60 medicines and other products and an international footprint

  • Interview: Harvey Berger and Timothy Clackson, Ariad Interview: Harvey Berger and Timothy Clackson, Ariad

    treatments.”. It's the results of strategy to “discover, develop and deliver our medicines without the additional input of pharma partners”, says Berger. ... We are building a strong commercial presence, but it is one that is built on what

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...